Anaptysbio ANAB
NASDAQ ANAB
$56.80 -0.66 (-1.15%)
As of: Sep 4, 2026 · 2:34 PM EDT

Anaptysbio (ANAB) Interest Coverage Ratio Growth (3y) (2019)

Analysis

Anaptysbio (ANAB) Interest Coverage Ratio Growth (3y) (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 29.79%
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -44.22%
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 33.30%
8 Royalty Pharma 28.40 Bn 27.56 Bn - -35.50%
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 81.16%
10 Anaptysbio 1.63 Bn 1.34 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -57.30%
Sep 30, 2019 -147.56%
Jun 30, 2019 -88.12%
Mar 31, 2019 -98.45%